Cite

HARVARD Citation

    Kingston, B. et al. (2017). Toxicity and Efficacy of ≥4th Line Palbociclib with Endocrine Therapy of Physician's Choice: a Single Centre Experience. Clinical oncology. 29 (6), pp. e100-. [Online]. 
  
Back to record